PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
06-Aug-2024 OS Therapies Announces Osteosarcoma Scientific and Medical Advisory Board AccessWire
06-Aug-2024 Catheter Precision, Inc. Announces Publication of LockeT Data in the Journal of Cardiovascular Electrophysiology AccessWire
06-Aug-2024 Aytu BioPharma Announces Sale of Consumer Health Business Following Wind Down of Consumer Health Operations AccessWire
06-Aug-2024 Sunshine Biopharma Announces Reverse Stock Split AccessWire
06-Aug-2024 Ainos Concludes Growth Financing From Lind Partners AccessWire
06-Aug-2024 Clinion Wins The Clinical Trials Arena Excellence Award 2024 for Innovation Clinion Inc
06-Aug-2024 Acreage Commences Non-Medical Cannabis Sales in Ohio AccessWire
06-Aug-2024 Protagonist Reports Second Quarter 2024 Financial Results and Provides Corporate Update AccessWire
06-Aug-2024 Formycon AG increases its outlook for the 2024 fiscal year Formycon AG
06-Aug-2024 QUANTRO Therapeutics secures important Austrian research grant to accelerate development of cutting-edge platform QUANTRO Therapeutics GmbH
06-Aug-2024 Biotest increases sales in the first half of 2024 by 35% to Euro 372 million Biotest AG
06-Aug-2024 Abivax Announces ABTECT Phase 3 Trial Achieves Key Enrollment Milestone ABIVAX
06-Aug-2024 Expansion of the Executive Committee and handover of the position of CFO Galenica AG
06-Aug-2024 Galenica achieves solid growth in a challenging market environment Galenica AG
05-Aug-2024 Ainos Reports Second Quarter 2024 Financial Results AccessWire
05-Aug-2024 Houston Medical Waste Disposal Company Tackles Piercing Surge in Needlestick Injuries With Essential Guide AccessWire
05-Aug-2024 Jaguar Health Issues Shareholder Letter: Company to Explore Approval Pathway for Crofelemer in Breast and Lung Cancer Based on Phase 3 Results - Investor Webcast August 13th Will Review Q2 Earnings and Further Review OnTarget Trial’s Clinically Meaningful Results AccessWire
05-Aug-2024 Vascular Therapies Completes Enrollment in the ACCESS 2 Study, a Phase III Multinational Randomized Clinical Trial of the Sirolimus Eluting Collagen Implant (Sirogen) for the Surgical Creation of Arteriovenous Fistula for Hemodialysis Vascular Access AccessWire
05-Aug-2024 Transforming Aesthetics: Dr. Maria Fedchuk's Journey of Innovation at MTS US AccessWire
05-Aug-2024 Eckert & Ziegler extends GalliaPharm® availability to the entire European Economic Area Eckert & Ziegler SE